![David Canner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Canner
Directeur/Bestuurslid bij
INHIBIKASE THERAPEUTICS, INC.
Vermogen: - $ op 30-06-2026
Profiel
David Canner is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024.
Dr. Canner is also a Partner at Soleus Capital LLC since 2018.
Dr. Canner holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 26-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van David Canner
| Bedrijven | Functie | Begin |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Bestuurslid | 21-10-2024 |
Soleus Capital LLC | Corporate Officer/Principal | 01-01-2018 |
Opleiding van David Canner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Soleus Capital LLC |
